Ceftibuten
- Generic Name
- Ceftibuten
- Brand Names
- Cedax
- Drug Type
- Small Molecule
- Chemical Formula
- C15H14N4O6S2
- CAS Number
- 97519-39-6
- Unique Ingredient Identifier
- IW71N46B4Y
- Background
Ceftibuten is a third-generation cephalosporin antibiotic that is orally-administered. It is typically used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.
- Indication
Indicated for the treatment of acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.
- Associated Conditions
- Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB), Acute Otitis Media (AOM), Acute Sinusitis, Acute Tracheobronchitis, Bacterial Infections, Bacterial Pneumonia, Lower Respiratory Tract Infection (LRTI), Lower Respiratory Tract Infection (LRTI) caused by susceptible bacteria, Pharyngitis, Skin and Soft Tissue Infections (SSTIs), Streptococcal Pharyngitis, Superinfection bacterial, Tonsillitis, Tonsillitis streptococcal, Upper Respiratory Tract Infection, Upper Respiratory Tract Infection caused by susceptible bacteria, Urinary Tract Infection caused by susceptible bacteria, Bacterial otitis media, Uncomplicated Lower Respiratory Tract Infection (LRTI), Uncomplicated Upper Respiratory Tract Infection, Uncomplicated Urethritis gonococcal
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath